| Literature DB >> 21854749 |
Ruben van Boxtel1, Raoul V Kuiper, Pim W Toonen, Sebastiaan van Heesch, Roel Hermsen, Alain de Bruin, Edwin Cuppen.
Abstract
The TP53 tumor suppressor gene is mutated in the majority of human cancers. Inactivation of p53 in a variety of animal models results in early-onset tumorigenesis, reflecting the importance of p53 as a gatekeeper tumor suppressor. We generated a mutant Tp53 allele in the rat using a target-selected mutagenesis approach. Here, we report that homozygosity for this allele results in complete loss of p53 function. Homozygous mutant rats predominantly develop sarcomas with an onset of 4 months of age with a high occurrence of pulmonary metastases. Heterozygous rats develop sarcomas starting at 8 months of age. Molecular analysis revealed that these tumors exhibit a loss-of-heterozygosity of the wild-type Tp53 allele. These unique features make this rat highly complementary to other rodent p53 knockout models and a versatile tool for investigating tumorigenesis processes as well as genotoxic studies.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21854749 PMCID: PMC3181367 DOI: 10.1016/j.ajpath.2011.06.036
Source DB: PubMed Journal: Am J Pathol ISSN: 0002-9440 Impact factor: 4.307